dc.contributor.author |
Stamatelopoulos, K |
en |
dc.contributor.author |
Lekakis, J |
en |
dc.contributor.author |
Poulakaki, N |
en |
dc.contributor.author |
Papamichael, C |
en |
dc.contributor.author |
Venetsanou, K |
en |
dc.contributor.author |
Aznaouridis, K |
en |
dc.contributor.author |
Protogerou, A |
en |
dc.contributor.author |
Papaioannou, T |
en |
dc.contributor.author |
Kumar, S |
en |
dc.contributor.author |
Stamatelopoulos, S |
en |
dc.date.accessioned |
2014-03-01T01:53:31Z |
|
dc.date.available |
2014-03-01T01:53:31Z |
|
dc.date.issued |
2004 |
en |
dc.identifier.uri |
https://dspace.lib.ntua.gr/xmlui/handle/123456789/27059 |
|
dc.subject |
Animal Studies |
en |
dc.subject |
Cardiovascular Risk Factor |
en |
dc.subject |
Carotid Intima Media Thickness |
en |
dc.subject |
Endothelial Function |
en |
dc.subject |
Follow-up Study |
en |
dc.subject |
Intima Media Thickness |
en |
dc.subject |
Postmenopausal Women |
en |
dc.subject |
Selective Estrogen Receptor Modulator |
en |
dc.subject |
Breast Cancer |
en |
dc.subject |
Common Carotid Artery |
en |
dc.title |
Tamoxifen improves endothelial function and reduces carotid intima-media thickness in postmenopausal women |
en |
heal.type |
journalArticle |
en |
heal.identifier.primary |
10.1016/j.ahj.2003.12.029 |
en |
heal.identifier.secondary |
http://dx.doi.org/10.1016/j.ahj.2003.12.029 |
en |
heal.publicationDate |
2004 |
en |
heal.abstract |
BackgroundTamoxifen is a selective estrogen-receptor modulator shown to improve several cardiovascular risk factors in postmenopausal women with breast cancer. In animal studies tamoxifen inhibits the progression of atherosclerosis. Although the presence of a history with tamoxifen treatment is related to a lower intima-media thickness (IMT) of the common carotid artery, data from controlled follow-up studies are lacking to support this |
en |
heal.journalName |
American Heart Journal |
en |
dc.identifier.doi |
10.1016/j.ahj.2003.12.029 |
en |